RE: LinkedIn28 Oct 2025 16:57
Agreed. This sub 2p is boring and an inadequate base from which to fly when commercialisation finally takes off. I really can’t see it extending beyond the next few weeks, but we have the unavoidable interruptions of the US’ inexplicable thanksgiving break and then of course the Xmas wind down. Here’s hoping we beat the calendar.
2.2 or 2.3 is where launch should be based. With the c-word news RNS bumping that rapidly onwards to 4 and to 6 and beyond if we get big Pharma interest ( to use or kill the science). I’ll be selling in steps at 3,4,5,6 and then holding for long term the remaining fifth.